Table 3.
Multilevel fixed effects for appraisals across drug, timepoint, and drug x timepoint.
| Predictors | b | β | S.E. | p | Lower 95% CI | Upper 95% CI |
|---|---|---|---|---|---|---|
| Mean challenge appraisals | ||||||
|
| ||||||
| Intercept | 3.81 | .00 | .791 | <.001 | 2.25 | 5.37 |
| Drug | .08 | .02 | .198 | .674 | −.31 | .48 |
| Post-TSST | −.55 | −.31 | .120 | <.001 | −.79 | −.32 |
| Drug x Post-TSST | −.10 | −.03 | .176 | .574 | −.45 | .25 |
| Sex | .17 | .09 | .179 | .351 | −.19 | .52 |
| BMI | −.13 | −.19 | .064 | .039 | −.26 | −.01 |
| SES | .05 | .11 | .047 | .254 | −.04 | .15 |
|
| ||||||
| Mean threat appraisals | ||||||
|
| ||||||
| Intercept | 4.99 | .00 | .887 | <.001 | 3.24 | 6.74 |
| Drug | −.30 | −.12 | .217 | .172 | −.73 | .13 |
| Post-TSST | .04 | .05 | .117 | .754 | −.20 | .27 |
| Drug x Post-TSST | .11 | .03 | .172 | .510 | −.23 | .45 |
| Sex | −.03 | −.01 | .201 | .895 | −.42 | .37 |
| BMI | .09 | .12 | .072 | .236 | −.06 | .23 |
| SES | −.06 | −.11 | .053 | .275 | −.16 | .05 |
|
| ||||||
| Mean negative appraisals | ||||||
|
| ||||||
| Intercept | 2.14 | .03 | .451 | <.001 | 1.25 | 3.03 |
| Drug | −.06 | −.14 | .112 | .592 | −.28 | .16 |
| Post-TSST | .38 | .28 | .070 | <.001 | .24 | .52 |
| Drug x Post-TSST | −.17 | −.08 | .102 | .102 | −.37 | .03 |
| Sex | .05 | .05 | .100 | .627 | −.15 | .25 |
| BMI | −.00 | −.01 | .036 | .935 | −.07 | .07 |
| SES | −.04 | −.15 | .027 | .116 | −.10 | .01 |
Note: Significant effects (p<.05) are bolded. Reference category was TSST Prep. SEs are with respect to the unstandardized coefficients.